Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 486

Similar articles for PubMed (Select 19801928)

1.

Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.

Maher SG, Gillham CM, Duggan SP, Smyth PC, Miller N, Muldoon C, O'Byrne KJ, Sheils OM, Hollywood D, Reynolds JV.

Ann Surg. 2009 Nov;250(5):729-37. doi: 10.1097/SLA.0b013e3181bce7e1.

PMID:
19801928
2.

Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.

Salnikova LE, Kolobkov DS.

Pharmacogenomics J. 2015 Jun 30. doi: 10.1038/tpj.2015.46. [Epub ahead of print]

PMID:
26122021
3.

Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation.

Hsu FM, Chia-Hsien Cheng J, Chang YL, Lee JM, Koong AC, Chuang EY.

Sci Rep. 2015 May 18;5:10291. doi: 10.1038/srep10291.

4.

Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.

Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim AC, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PA, Camargo AA.

Cancer Genet. 2015 Mar 25. pii: S2210-7762(15)00041-1. doi: 10.1016/j.cancergen.2015.03.010. [Epub ahead of print]

PMID:
25963525
5.

Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.

Yip C, Cook GJ, Landau DB, Davies A, Goh V.

Dis Esophagus. 2015 Jan 21. doi: 10.1111/dote.12315. [Epub ahead of print] No abstract available.

PMID:
25604614
6.

Neoadjuvant chemoradiotherapy for stage I and II esophageal cancer.

van Rossum PS, van Hillegersberg R, Reerink O, Ruurda JP.

J Clin Oncol. 2015 Jan 20;33(3):287-8. doi: 10.1200/JCO.2014.58.1272. Epub 2014 Dec 1. No abstract available.

PMID:
25452449
7.

Effectiveness of neoadjuvant chemoradiotherapy for early-stage esophageal cancer.

Shapiro J, van Lanschot JJ, Hulshof MC, van der Gaast A.

J Clin Oncol. 2015 Jan 20;33(3):288-9. doi: 10.1200/JCO.2014.59.2428. Epub 2014 Dec 1. No abstract available.

PMID:
25452442
8.

Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.

Palma P, Cano C, Conde-Muiño R, Comino A, Bueno P, Ferrón JA, Cuadros M.

PLoS One. 2014 Nov 7;9(11):e112189. doi: 10.1371/journal.pone.0112189. eCollection 2014.

9.

Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy: A Pilot Study.

Rebollo J, Sureda M, Martinez EM, Fernández-Morejón FJ, Farré J, Muñoz V, Fernández-Latorre F, Manzano RG, Brugarolas A.

Am J Clin Oncol. 2014 Aug 20. [Epub ahead of print]

PMID:
25144266
10.

Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

Uemura N, Kondo T.

World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):322-34. doi: 10.4291/wjgp.v5.i3.322. Review.

11.

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.

Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X.

Cancer. 2014 Dec 1;120(23):3635-41. doi: 10.1002/cncr.28911. Epub 2014 Aug 4.

12.

Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.

Wen J, Yang H, Liu MZ, Luo KJ, Liu H, Hu Y, Zhang X, Lai RC, Lin T, Wang HY, Fu JH.

Ann Oncol. 2014 Sep;25(9):1769-74. doi: 10.1093/annonc/mdu201. Epub 2014 Jun 6.

PMID:
24907633
13.

Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa.

van Rossum PS, van Hillegersberg R, Meijer GJ, Ruurda JP.

Ann Surg. 2014 Apr 16. [Epub ahead of print] No abstract available.

PMID:
24743619
14.

Reply to Letter: "Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa"

Shapiro J, Wijnhoven BP, van Lanschot JJ.

Ann Surg. 2014 Apr 16. [Epub ahead of print] No abstract available.

PMID:
24743617
15.

A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.

Chan J, Kinsella MT, Willis JE, Hu H, Reynolds H Jr, Delaney C, McCulla A, Deharo S, Ahdesmäki M, Allen WL, Johnston PG, Kinsella TJ.

Front Oncol. 2013 Nov 25;3:288. doi: 10.3389/fonc.2013.00288. eCollection 2013.

16.

Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes.

Watanabe T, Kobunai T, Akiyoshi T, Matsuda K, Ishihara S, Nozawa K.

Dis Colon Rectum. 2014 Jan;57(1):23-31. doi: 10.1097/01.dcr.0000437688.33795.9d.

PMID:
24316942
17.

ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.

Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D.

Mol Oncol. 2014 Feb;8(1):142-9. doi: 10.1016/j.molonc.2013.10.007. Epub 2013 Oct 28.

18.

[Biomarkers of predicting response to neoadjuvant chemoradiotherapy in esophageal cancer].

Fu JH.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Sep;16(9):805-10. Chinese.

PMID:
24061981
19.

Prediction of response to treatment by gene expression profiling of peripheral blood in patients with microscopic polyangiitis.

Ishizu A, Tomaru U, Murai T, Yamamoto T, Atsumi T, Yoshiki T, Yumura W, Yamagata K, Yamada H, Kumagai S, Kurokawa MS, Suka M, Makino H, Ozaki S; JMAAV.

PLoS One. 2013 May 17;8(5):e63182. doi: 10.1371/journal.pone.0063182. Print 2013.

20.

MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response.

Odenthal M, Bollschweiler E, Grimminger PP, Schröder W, Brabender J, Drebber U, Hölscher AH, Metzger R, Vallböhmer D.

Int J Cancer. 2013 Nov 15;133(10):2454-63. doi: 10.1002/ijc.28253. Epub 2013 Jun 3.

PMID:
23649428
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk